We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

CEL-SCI Initiates Development of Immunotherapy to Treat COVID-19 Coronavirus Infection

Product News   Mar 09, 2020

 
CEL-SCI Initiates Development of Immunotherapy to Treat COVID-19 Coronavirus Infection
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Clinical Validation of Portable Rapid Testing Kit for Coronavirus

Product News

MicrosensDx has announced that the test for research use in the detection of RNA from the SARS-Cov-2 virus in sputum, throat and nose swabs has now been assessed for clinical performance

READ MORE

Success in Next Phase of Open Source Malaria Initiative

Product News

Optibrium™ and Intellegens™ have successfully completed phase 2 of a global challenge aimed at developing and testing novel antimalarial compounds.

READ MORE

Proteomics Enters the COVID-19 Fight

Product News

SomaLogic has launched a new initiative to deploy their proteomic technology against the coronavirus pandemic.

READ MORE

Like what you just read? You can find similar content on the communities below.

Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE